Article Details

Apexigen Announces New Data from a Phase 2 Trial Evaluating its CD40 Antibody ...

Retrieved on: 2022-04-13 07:01:11

Tags for this article:

Click the tags to see associated articles and topics

Apexigen Announces New Data from a Phase 2 Trial Evaluating its CD40 Antibody .... View article details on hiswai:

Excerpt

... presentation of data from a Phase 2 clinical trial evaluating intratumoral sotigalimab (sotiga), Apexigen's monoclonal antibody targeting CD40 ...

Article found on: www.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up